J Liver Cancer Search

CLOSE


Review Article

September 30, 2019


Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma
Jong Man Kim
J Korean Liver Cancer Stud. 2019;19(2):85-90.

Review Article

September 30, 2019


Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass
Min Kyu Kang, Moon Young Kim, Seong Hee Kang, et al.
J Korean Liver Cancer Stud. 2019;19(2):91-96.

Review Article

September 30, 2019


The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma
Sun Young Yim, Ju-Seog Lee
J Korean Liver Cancer Stud. 2019;19(2):97-107.

Original Article

September 30, 2019


Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
Hye Won Lee, Kyung Joo Cho, Soon Young Shin, et al.
J Korean Liver Cancer Stud. 2019;19(2):108-116.

Original Article

September 30, 2019


An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era
Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, et al.
J Korean Liver Cancer Stud. 2019;19(2):117-127.

Original Article

September 30, 2019


Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Young Youn Cho, Young Hwan Choi, Su Jong Yu, et al.
J Korean Liver Cancer Stud. 2019;19(2):128-135.

Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma
Jong Man Kim
J Liver Cancer. 2019;19(2):85-90.

Review Article

September 30, 2019

Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass
Min Kyu Kang, Moon Young Kim, Seong Hee Kang, et al.
J Liver Cancer. 2019;19(2):91-96.

Review Article

September 30, 2019

The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma
Sun Young Yim, Ju-Seog Lee
J Liver Cancer. 2019;19(2):97-107.

Review Article

September 30, 2019

Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
Hye Won Lee, Kyung Joo Cho, Soon Young Shin, et al.
J Liver Cancer. 2019;19(2):108-116.

Original Article

September 30, 2019

An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era
Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, et al.
J Liver Cancer. 2019;19(2):117-127.

Original Article

September 30, 2019

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Young Youn Cho, Young Hwan Choi, Su Jong Yu, et al.
J Liver Cancer. 2019;19(2):128-135.

Original Article

September 30, 2019

Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma
Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, et al.
J Liver Cancer. 2019;19(2):136-142.

Case Report

September 30, 2019

Malignant Hepatic Solitary Fibrous Tumor
Hong Il Kim, Seok Kyung In, Hyung Suk Yi, et al.
J Liver Cancer. 2019;19(2):143-148.

Case Report

September 30, 2019

Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium
Sunmin Park, Won Sup Yoon, Hyung Joon Yim, et al.
J Liver Cancer. 2019;19(2):149-153.

Case Report

September 30, 2019

Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event
Dae-ha Kim, Minkoo Kim, Hyung Joon Yim, et al.
J Liver Cancer. 2019;19(2):154-158.

Case Report

September 30, 2019

Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization
Jun Sik Yoon, Su Jong Yu, Yun Bin Lee, et al.
J Liver Cancer. 2019;19(2):159-164.

Case Report

September 30, 2019

Early Onset Polymorphic Post-transplant Lymphoproliferative Disease Mimicking a Solitary Necrotizing Abscess in a Graft Liver
Pil Soo Sung, Jaejun Lee, Joon Lee, et al.
J Liver Cancer. 2019;19(2):165-170.

Case Report

September 30, 2019

  • KoreaMed
  • KoMCI
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID

ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2019 by The Korean Liver Cancer Association. All rights reserved.

Developed in M2community

Close layer
prev next
Close layer
prev next